文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003.

作者信息

Chevalier Jacqueline, Mulfinger Céline, Garnotel Eric, Nicolas Pierre, Davin-Régli Anne, Pagès Jean-Marie

机构信息

UMR-MD1, IFR 48, Facultés de Médecine et de Pharmacie, Marseille, France.

出版信息

PLoS One. 2008 Sep 12;3(9):e3203. doi: 10.1371/journal.pone.0003203.


DOI:10.1371/journal.pone.0003203
PMID:18787654
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2527680/
Abstract

BACKGROUND: The high mortality impact of infectious diseases will increase due to accelerated evolution of antibiotic resistance in important human pathogens. Development of antibiotic resistance is a evolutionary process inducing the erosion of the effectiveness of our arsenal of antibiotics. Resistance is not necessarily limited to a single class of antibacterial agents but may affect many unrelated compounds; this is termed 'multidrug resistance' (MDR). The major mechanism of MDR is the active expulsion of drugs by bacterial pumps; the treatment of gram negative bacterial infections is compromised due to resistance mechanisms including the expression of efflux pumps that actively expel various usual antibiotics (beta-lactams, quinolones, ...). METHODOLOGY/PRINCIPAL FINDINGS: Enterobacter aerogenes has emerged among Enterobacteriaceae associated hospital infections during the last twenty years due to its faculty of adaptation to antibiotic stresses. Clinical isolates of E. aerogenes belonging to two strain collections isolated in 1995 and 2003 respectively, were screened to assess the involvement of efflux pumps in antibiotic resistance. Drug susceptibility assays were performed on all bacterial isolates and an efflux pump inhibitor (PAbetaN) previously characterized allowed to decipher the role of efflux in the resistance. Accumulation of labelled chloramphenicol was monitored in the presence of an energy poison to determine the involvement of active efflux on the antibiotic intracellular concentrations. The presence of the PAbetaN-susceptible efflux system was also identified in resistant E. aerogenes strains. CONCLUSIONS/SIGNIFICANCE: For the first time a noticeable increase in clinical isolates containing an efflux mechanism susceptible to pump inhibitor is report within an 8 year period. After the emergence of extended spectrum beta-lactamases in E. aerogenes and the recent characterisation of porin mutations in clinical isolates, this study describing an increase in inhibitor-susceptible efflux throws light on a new step in the evolution of mechanism in E. aerogenes.

摘要

相似文献

[1]
Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003.

PLoS One. 2008-9-12

[2]
Ram locus is a key regulator to trigger multidrug resistance in Enterobacter aerogenes.

J Med Microbiol. 2018-2

[3]
Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes.

Biochem Biophys Res Commun. 2003-2-21

[4]
Physiological characterisation of the efflux pump system of antibiotic-susceptible and multidrug-resistant Enterobacter aerogenes.

Int J Antimicrob Agents. 2010-8-4

[5]
Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes.

Microbiology (Reading). 1998-11

[6]
Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant Enterobacter aerogenes isolates.

Curr Drug Targets. 2006-7

[7]
Chloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates.

Int J Antimicrob Agents. 2006-6

[8]
Detection of New Delhi Metallo-β-Lactamase Variants NDM-4, NDM-5, and NDM-7 in Enterobacter aerogenes Isolated from a Neonatal Intensive Care Unit of a North India Hospital: A First Report.

Microb Drug Resist. 2018-3

[9]
Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates.

Biochem J. 2003-12-15

[10]
Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strains.

Biochem Biophys Res Commun. 2002-5-24

引用本文的文献

[1]
First report of coexistence of blaKPC-2 and blaNDM-1 in carbapenem-resistant clinical isolates of in Brazil.

Front Microbiol. 2024-2-14

[2]
Whole-genome sequencing analysis of among men who have sex with men in Guangzhou, China.

Front Microbiol. 2023-6-2

[3]
Antibiotic properties of Satureja montana L. hydrolate in bacteria and fungus of clinical interest and its impact in non-target environmental microorganisms.

Sci Rep. 2022-11-2

[4]
Clinical Status of Efflux Resistance Mechanisms in Gram-Negative Bacteria.

Antibiotics (Basel). 2021-9-16

[5]
Antimicrobial Resistance in ESKAPE Pathogens.

Clin Microbiol Rev. 2020-6-17

[6]
Coexistence of and on a Transferrable Plasmid of a Novel ST192 Clinical Isolate.

Infect Drug Resist. 2019-12-13

[7]
spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance.

Clin Microbiol Rev. 2019-7-17

[8]
Establishment of a Molecular Serotyping Scheme and a Multiplexed Luminex-Based Array for .

Front Microbiol. 2018-3-19

[9]
Infections Caused by Antimicrobial Drug-Resistant Saprophytic Gram-Negative Bacteria in the Environment.

Front Med (Lausanne). 2017-10-30

[10]
Editorial: Alternative Therapeutics against MDR Bacteria - "Fighting the Epidemic of Antibiotic Resistance".

Front Microbiol. 2016-10-7

本文引用的文献

[1]
Regulation of the MtrC-MtrD-MtrE efflux-pump system modulates the in vivo fitness of Neisseria gonorrhoeae.

J Infect Dis. 2007-12-15

[2]
High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal.

J Antimicrob Chemother. 2007-12

[3]
Antibiotic stress, genetic response and altered permeability of E. coli.

PLoS One. 2007-4-11

[4]
The endemic situation of Enterobacter aerogenes and Enterobacter cloacae: you will only discover what you are looking for.

J Hosp Infect. 2007-4

[5]
Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure.

J Antimicrob Chemother. 2006-12

[6]
Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.

J Antimicrob Chemother. 2006-9

[7]
Multidrug-resistance efflux pumps - not just for resistance.

Nat Rev Microbiol. 2006-8

[8]
European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe.

J Antimicrob Chemother. 2006-8

[9]
Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates.

Antimicrob Agents Chemother. 2006-5

[10]
Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Clin Microbiol Rev. 2006-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索